First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.

Ann Intern Med

Section of General Internal Medicine and Center for Chronic Disease Research and Policy, Department of Medicine, University of Chicago, Chicago, Illinois.

Published: April 2023

Download full-text PDF

Source
http://dx.doi.org/10.7326/L23-0007DOI Listing

Publication Analysis

Top Keywords

first-line therapy
4
therapy type
4
type diabetes
4
diabetes sodium-glucose
4
sodium-glucose cotransporter-2
4
cotransporter-2 inhibitors
4
inhibitors glucagon-like
4
glucagon-like peptide-1
4
peptide-1 receptor
4
receptor agonists
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!